Patients and Patents https://validator.w3.org/feed/docs/rss2.html Patients and patents campaign Gaming the system: An overview of originator companies’ evergreening strategies used to hinder access to generic and biosimilar products “Canada’s drug access debate has two ends: patients are caught in the middle,” Op-Ed by Arthritis Consumer Experts (ACE) Patients and patents campaign partners launch website Advocacy Toolkit Interview: Patients and patents – Understanding how pharmaceutical patents affect medication cost Join The Conversation About The Campaign How Pharmaceutical Patents Work News Common Questions About Patents Why are drug prices so high? Market access barriers Do drugs get cheaper when their patents expire? Beyond regulatory delays: How patent misuse impacts access to affordable medications How pharmaceutical patents make drugs expensive The unspoken cost of pharma IP protections from trade agreements Glossary